Low molecular weight heparin (LMWH) increases the efficacy of cisplatinum plus gemcitabine combination in advanced pancreatic cancer

Icli, Fikri; AKBULUT, HAKAN; Utkan, Gungor; Yalcin, Bulent; Dincol, Dilek; Isikdogan, Abdurrahman; DEMİRKAZIK, AHMET; Onur, Handan; Cay, Filiz; Buyukcelik, Abdullah

doi:10.1002/jso.20728

Low molecular weight heparin (LMWH) increases the efficacy of cisplatinum plus gemcitabine combination in advanced pancreatic cancer

Icli F., AKBULUT H., Utkan G., Yalcin B., Dincol D., Isikdogan A., ...More

JOURNAL OF SURGICAL ONCOLOGY, vol.95, no.6, pp.507-512, 2007 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 95 Issue: 6
Publication Date: 2007
Doi Number: 10.1002/jso.20728
Journal Name: JOURNAL OF SURGICAL ONCOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.507-512
Keywords: advanced pancreatic carcinoma, low molecular weight heparin, cisplatin, gemcitabine, nadroparine, RECURRENT VENOUS THROMBOEMBOLISM, CELL LUNG-CANCER, RANDOMIZED-TRIAL, IN-VITRO, CARCINOMA, WARFARIN, SURVIVAL, PHASE, ANTICOAGULATION, CHEMOTHERAPY
Lokman Hekim University Affiliated: No

Abstract

Background: In this non-randomized study we aimed to assess the efficacy of the addition of low molecular weight heparin (LMWH) to gemcitabine (GEM) plus cisplatinum (CDDP) combination chemotherapy on survival by prevention of thromboembolic complications in patients with advanced pancreatic cancer (APC).